Alison Lawrie Selected Research

MVA 85A

4/2021	Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults.
1/2020	A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
1/2018	Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A.
4/2012	A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.
6/2011	Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
1/2010	Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alison Lawrie Research Topics

Disease

8	Malaria 02/2024 - 01/2010
7	Tuberculosis (Tuberculoses) 04/2024 - 01/2010
6	Vaccinia 08/2021 - 01/2010
5	Infections 04/2024 - 04/2012
2	Parasitemia 01/2021 - 05/2015
1	Ovarian Cysts (Ovarian Cyst) 04/2024
1	Pulmonary Tuberculosis 04/2024
1	Fever (Fevers) 02/2024
1	Pain (Aches) 02/2024
1	Rift Valley Fever 01/2023
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021
1	COVID-19 01/2021
1	Bites and Stings (Sting) 01/2021
1	Human Influenza (Influenza) 03/2019
1	Ebola Hemorrhagic Fever 01/2019
1	Schistosomiasis mansoni 01/2018
1	Vesicular Stomatitis 04/2016
1	Lung Diseases (Lung Disease) 03/2016

Drug/Important Bio-Agent (IBA)

17	VaccinesIBA 04/2024 - 01/2010
6	MVA 85AIBA 04/2021 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 08/2021 - 05/2015
4	Matrix-MIBA 02/2024 - 10/2017
4	AntibodiesIBA 01/2023 - 01/2010
3	EpitopesIBA 01/2021 - 05/2015
3	ThrombospondinsIBA 01/2021 - 05/2015
3	Tuberculosis VaccinesIBA 03/2016 - 01/2010
2	AerosolsIBA 04/2024 - 04/2021
2	Malaria VaccinesIBA 02/2024 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 01/2023 - 04/2016
2	Rabies Vaccines (Rabies Vaccine)FDA Link 12/2022 - 05/2015
1	rabivaxIBA 12/2022
1	NucleoproteinsIBA 08/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2021
1	Combined VaccinesIBA 08/2021
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2021
1	asparaginyl-prolineIBA 01/2021
1	AntigensIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	A-Form DNA (A-DNA)IBA 01/2021
1	Ebola VaccinesIBA 01/2019
1	Neutralizing AntibodiesIBA 04/2016
1	Antimalarials (Antimalarial Agents)IBA 05/2015
1	Peptides (Polypeptides)IBA 05/2015

Therapy/Procedure

1	Analgesia 04/2024